Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVolution Group PLS Regulatory News (FAN)

Share Price Information for Volution Group PLS (FAN)

Share Price is delayed by 15 minutes
Get Live Data
605.00    4.00 (0.67%)
Bid:
604.00
Ask:
606.00
Spread: 2.00 (0.331%)
Market Cap: £1.20b
FAN Live PriceLast checked at - London Stock Exchange

Intraday Volution Group PLS Share Chart

Pre-Close Trading Update

24 Jul 2025 07:00

RNS Number : 3161S
Volution Group plc
24 July 2025
 

 

Thursday 24 July 2025

 

Volution Group plc

 

Pre-close Trading Update for the Financial Year ending 31 July 2025

Continued good progress; expect adjusted EPS slightly ahead of current market consensus

 

Volution Group plc ("Volution" or "the Group" or "the Company", LSE: FAN), a leading international designer and manufacturer of energy efficient indoor air quality solutions, provides its scheduled Pre-close Trading Update for the financial year ending 31 July 2025 ("FY25").

 

Volution has continued to make good progress in FY25 and the Board expects adjusted earnings per share to be slightly ahead of current market consensus (see note 1).

 

The Board is expecting to deliver organic revenue growth on a constant currency (cc) basis for FY25 of over 5%, up from 4% at the half year. Total Group revenue growth is expected to be over 20%(cc), which includes eight months contribution from Fantech, acquired in December 2024.

 

On a Regional view:

· Strong organic growth in the UK has been underpinned by continued growth in residential revenue. Within this our refurbishment demand has remained resilient against a backdrop of generally weak market conditions. Our new residential house building revenue has performed very well, supported by regulations and our leading low carbon product range. Exports to Ireland which are similarly focused on residential new build systems have been strong. Commercial revenue has returned to growth following a weak first half.

· Continental European revenue growth is expected to be slightly stronger in the second half than in the first half. Performance in the Nordics has continued broadly in line with the first half, with Swedish refurbishment performing relatively well and weaker demand in the new construction activities. Central Europe has performed strongly in the year, driven by our heat recovery propositions in ClimaRad and ERI, and by VMI in France where we continue to focus on broadening the product range through the introduction of new products from across the Group.

· In Australasia, second half market conditions and organic revenue performance have continued to remain broadly unchanged from the first half, with a challenging demand picture in New Zealand contrasting with a good performance in Australia. The integration of Fantech into the Group is going very well, with a strong revenue performance in the eight months post-acquisition.

 

We expect Group adjusted operating margins to be broadly in line with the first half of the year, with operating margins on an organic basis expected to increase modestly, offset by the inorganic dilution from the acquisition of Fantech. Fantech's second half performance has been encouraging, and we are confident in its trajectory to reach the Group's 20% operating margin target in the medium term.

 

The weakening of overseas currencies, most notably the Australian and New Zealand dollars, has had a negative translation impact in the financial year of approximately £5 million to revenue and just over £1 million to adjusted operating profit.

 

Operating cash conversion (note 2) is expected to be above our targeted level of 90%, assisted by strong management of inventory and good working capital management across the Group. The strength of our cash generation gives us good capacity for future investment and earnings accretive acquisitions.

 

Ronnie George, Volution Chief Executive Officer, commented:

"Volution has delivered good progress during the second half of the year with organic growth expected to be slightly ahead of our target range of 3-5%. The acquisition of Fantech, our largest to date, is going well, and integration has progressed in line with our expectations. I am hugely grateful to all our local teams' endeavours in supplying leading air quality solutions and providing our customers with "healthy air, sustainably".

"Given our good progress in the second half of the year, the Board now expects adjusted earnings per share to be slightly ahead of current market consensus for FY25."

The full year results for the year ending 31 July 2025 will be announced on Thursday, 9 October 2025.

 

-ends-

For further information: 

Volution Group plc

 

Ronnie George, Chief Executive Officer

+44 (0) 1293 441501

Andy O'Brien, Chief Financial Officer

+44 (0) 1293 441536

 

FTI Consulting

+44 (0) 203 727 1340

Richard Mountain

Susanne Yule

Note:

1. Current market forecasts for the year ending 31 July 2025 (taken from Bloomberg) are:

· Adjusted earnings per share in the range of 31.6p to 32.5p with a consensus of 32p

2. Cash conversion defined as: Adjusted operating cash flow / (Adjusted operating profit + amortisation). 

 

Volution Group plc Legal Entity Identifier: 213800EPT84EQCDHO768.

 

Note to Editors:

 

Volution Group plc (LSE: FAN) is a leading international designer and manufacturer of energy efficient indoor air quality solutions. Volution Group comprises 29 key brands across three regions:

 

UK: Vent-Axia, Manrose, Diffusion, National Ventilation, Airtech, Breathing Buildings, Torin-Sifan.

Continental Europe: Fresh, PAX, VoltAir, Kair, Air Connection, Rtek, inVENTer, Ventilair, ClimaRad, ERI Corporation, VMI, I-Vent.

Australasia: Simx, Ventair, Manrose, DVS, Fantech, Ideal Air, NCS Acoustics, Air Design, Major Air, Systemaire, Burra Steel.

 

For more information, please go to: www.volutiongroupplc.com

 

Cautionary statement regarding forward-looking statements

This document may contain forward-looking statements which are made in good faith and are based on current expectations or beliefs, as well as assumptions about future events. You can sometimes, but not always, identify these statements by the use of a date in the future or such words as "will", "anticipate", "estimate", "expect", "project", "intend", "plan", "should", "may", "assume" and other similar words. By their nature, forward-looking statements are inherently predictive and speculative and involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. You should not place undue reliance on these forward-looking statements, which are not a guarantee of future performance and are subject to factors that could cause our actual results to differ materially from those expressed or implied by these statements. The Company undertakes no obligation to update any forward-looking statements contained in this document, whether as a result of new information, future events or otherwise.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPKNBBOBKDOOB
Date   Source Headline
3rd Jun 20262:00 pmRNSHolding(s) in Company
14th May 202612:54 pmRNSHolding(s) in Company
1st May 20265:45 pmRNSTotal Voting Rights
30th Apr 20265:59 pmRNSHolding(s) in Company
10th Apr 202611:00 amRNSHolding(s) in Company
1st Apr 20269:22 amRNSTotal Voting Rights
16th Mar 20269:20 amRNSHolding(s) in Company
12th Mar 20267:00 amRNSHalf Year Results
2nd Mar 20265:05 pmRNSTotal Voting Rights
24th Feb 202610:35 amRNSNotice of Half Year Results
2nd Feb 20261:00 pmRNSTotal Voting Rights
2nd Feb 20267:00 amRNSCompletion of AC Industries Acquisition
26th Jan 20264:00 pmRNSDirector/PDMR Shareholding
23rd Jan 202610:05 amRNSHolding(s) in Company
2nd Jan 202611:30 amRNSTotal Voting Rights
11th Dec 20253:00 pmRNSHolding(s) in Company
10th Dec 20254:50 pmRNSResult of AGM
10th Dec 20257:01 amRNSAgreement to acquire AC Industries in Australia
10th Dec 20257:00 amRNSAGM Trading Update
3rd Dec 20254:00 pmRNSHoldings in Company
1st Dec 20255:55 pmRNSTotal Voting Rights
19th Nov 20253:30 pmRNSDirector Declaration
12th Nov 20251:10 pmRNSDirector/PDMR Shareholding
11th Nov 20259:45 amRNSHolding(s) in Company
3rd Nov 20255:00 pmRNSTotal Voting Rights
24th Oct 202512:17 pmRNSShare Purchase by Chairman
22nd Oct 20253:45 pmRNSAnnual Report 2025 & Notice of AGM
17th Oct 20255:45 pmRNSDirector/PDMR Shareholding
16th Oct 20254:40 pmRNSLTIP and DSBP Awards
15th Oct 20255:03 pmRNSDirector/PDMR Shareholding
9th Oct 20251:25 pmRNSHolding(s) in Company
9th Oct 20257:00 amRNSPreliminary Results for year ended 31 July 2025
1st Oct 20255:52 pmRNSTotal Voting Rights
1st Sep 20255:45 pmRNSTotal Voting Rights
27th Aug 202511:11 amRNSHolding(s) in Company
15th Aug 20258:50 amRNSHolding(s) in Company
1st Aug 20255:55 pmRNSTotal Voting Rights
24th Jul 20257:00 amRNSPre-Close Trading Update
21st Jul 20257:00 amRNSNotice of Pre-Close Trading Update
11th Jul 20257:00 amRNSBoard and Committee Changes
1st Jul 20252:16 pmRNSTotal Voting Rights
2nd Jun 20251:00 pmRNSTotal Voting Rights
22nd May 20259:04 amRNSDirector Declaration
1st May 20255:30 pmRNSTotal Voting Rights
1st Apr 20255:45 pmRNSTotal Voting Rights
14th Mar 20255:20 pmRNSHolding(s) in Company
13th Mar 20257:00 amRNSHalf Year Results
5th Mar 20257:00 amRNSBoard Appointments
3rd Mar 20255:45 pmRNSTotal Voting Rights
24th Feb 202511:10 amRNSNotice of Half Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.